Neuralstem, Inc. (NASDAQ:CUR) tinted gains of +7.83% (+0.09 points) to US$1.24. The volume of 0.13 Million shares climbed down over an trading activity of 108.39 Million shares. EPS ratio determined by looking at last 12 month figures is -0.76. Over the same time span, the stock marked US$6.05 as its best level and the lowest price reached was US$0.88. The corporation has a market cap of US$18.33 Million.
Neuralstem, Inc. (NASDAQ:CUR)’s earnings per share has been growing at a 11.9 percent rate over the past 5 year when average revenue increase was noted as -8.6 percent. The return on equity ratio or ROE stands at -119.3 percent while most common profitability ratio return on investment (ROI) was -156.6 percent. The company’s institutional ownership is monitored at 16.3 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin.
Cemtrex, Inc. (NASDAQ:CETX) is worth US$25.89 Million and has recently risen 7.77% to US$2.22. The latest exchange of 0.07 Million shares is below its average trading activity of 49.55 Million shares. The day began at US$0 but the price moved to US$0 at one point during the trading and finally capitulating to a session high of US$0. The stock tapped a 52-week high of US$3.71 while the mean 12-month price target for the shares is US$4.
Currently, the stock carries a price to earnings ratio of 8.04, a price to book ratio of 0.55, and a price to sales ratio of 0.23. For the past 5 years, the company’s revenue has grown 58.2%, while the company’s earnings per share has grown 24.4%. With an institutional ownership near 6.4%, it carries an earnings per share ratio of 0.28.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.